Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Neon Healthcare Limited, Mill Studio Business Centre, Crane Mead, Ware, Hertfordshire, SG12 9PY, UK
Anquil 0.25 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White tablets, marked with “025” on one side and a breakline line on the other. |
Each tablet contains 0.25 mg benperidol.
Excipient with known effect: 79.75 mg lactose per tablet.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Benperidol |
Benperidol is a strong dopamine receptor antagonist with weaker serotonin receptor antagonism. In high doses, it has antihistaminergic and alpha-adrenergic properties. It possesses minimal anticholinergic properties. Benperidol is a typical antipsychotic primarily used to treat hypersexuality syndromes and can be used to treat schizophrenia. |
| List of Excipients |
|---|
|
Lactose |
The tablets are supplied in blister packs, containing 100 or 112 tablets.
Not all pack sizes may be marketed.
Neon Healthcare Limited, Mill Studio Business Centre, Crane Mead, Ware, Hertfordshire, SG12 9PY, UK
PL 45043/0031
02/08/2006
| Drug | Countries | |
|---|---|---|
| ANQUIL | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
